Recombinant IgG4 monovalent antibodies
US9322035B2 · kind B2 · utility
1Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2008 |
| Grant date | Apr 26, 2016 |
| Priority date | — |
| Expiry date | Feb 16, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16011
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to novel non-human transgenic animals, which upon antigenic stimulation are capable of producing monovalent antibodies binding to a selected antigen, modified heavy chain transgenes, methods for producing the non-human transgenic animals, methods for immunizing the non-human transgenic animals for as well as monovalent antibodies obtainable by such immunization methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.